Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
Sales 2017 | 35.9M 38.39M 3.2B | Sales 2018 | 41.5M 44.37M 3.7B | Capitalization | 56.19M 60.08M 5.01B |
---|---|---|---|---|---|
Net income 2017 | 4M 4.28M 357M | Net income 2018 | 3M 3.21M 268M | EV / Sales 2017 | 1.85 x |
Net Debt 2017 | 5.9M 6.3M 526M | Net Debt 2018 | 10.55M 11.28M 941M | EV / Sales 2018 | 1.61 x |
P/E ratio 2017 |
14.7
x | P/E ratio 2018 |
14.1
x | Employees | - |
Yield 2017 |
1.11% | Yield 2018 |
1.98% | Free-Float | 20.71% |
Managers | Title | Age | Since |
---|---|---|---|
Vanni Benedetti
CEO | Chief Executive Officer | 55 | 02/86/02 |
Luca Sforazzini
BRD | Director/Board Member | 49 | 10/11/10 |
Roberto Nisica
BRD | Director/Board Member | 59 | 03/10/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vanni Benedetti
CEO | Chief Executive Officer | 55 | 02/86/02 |
Roberto Nisica
BRD | Director/Board Member | 59 | 03/10/03 |
Enrico Russo
BRD | Director/Board Member | 38 | 01/10/01 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 80.72M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BIO2 Stock